Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei

Abstract excerpt

Burkholderia pseudomallei is the etiological agent of melioidosis. Because of the bacterium's intrinsic resistance and propensity to establish latent infections, melioidosis therapy is complicated and prolonged. Newer generation β-lactams, specifically ceftazidime, are used for acute phase therapy, but resistance to this cephalosporin has been observed. The chromosomally encoded penA gene encodes a putative twin...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Burkholderia infections and melioidosis